The overweight population and the incidence of type 2 diabetes are growing in China as the economy develops, the population ages, and the lifestyle changes. The number of people with type 2 diabetes exceeded 110 million at the end of 2017, and is still rising.
Taken by mouth, Gliclazide is a second-generation sulfonylurea to treat diabetes by stimulating insulin secretion from pancreatic β-cells. It can protect pancreatic β-cells from the apoptosis caused by hyperglycemia, and prevent atherosclerosis (build-up of fatty deposits in the arteries) caused by type 2 diabetes.
Developed by French company Servier, Gliclazide (trade name: Diamicron) was first launched in France in 1972, and entered China in the 1980s. In China, at least 200,000 people with type 2 diabetes are taking Gliclazide every year. In 1987, Tianjin Huajin Pharmaceutical Factory (now known as Tianjin Huajin Pharmaceutical Co., Ltd.) started cooperating with Servier and Tianjin Pharmaceutical Station to produce Gliclazide (Diamicron), a new drug to treat type 2 diabetes. With the support of Servier, the company has been taking the leading position on China's Gliclazide market. Also dominating the market are Servier and Servier (Tianjin) Pharmaceutical Co., Ltd., the joint venture of Servier and Tianjin Huajin Pharmaceutical Co., Ltd.
According to the researcher, the sales value of Gliclazide kept rising after the drug entered China, and exceeded CNY 200 million in 2017. It is expected that China's Gliclazide market will continue to grow as the incidence of type 2 diabetes rises.
1 Relevant Concepts of Gliclazide
1.1 Indications for Gliclazide
1.2 Development History of Gliclazide in China
1.3 Governmental Approval of Gliclazide in China
2 Sales of Gliclazide in China, 2013-2017
2.1 Sales Value
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Gliclazide by Dosage Form in China, 2013-2017
3 Analysis on Major Gliclazide Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Gliclazide Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2.1 Enterprise Profile
3.2.2 Sales of Servier's Gliclazide in China
3.3 Servier (Tianjin) Pharmaceutical Co., Ltd.
3.4 Tianjin Huajin Pharmaceutical Co. Ltd.
3.5 Nanchang Helioeast Pharmaceutical Co., Ltd.
3.6 Guilin Hwasun Pharmaceutical Co., Ltd.
4 Prices of Gliclazide in China, 2017-2018
4.1 Servier (Diamicron)
4.2 Servier (Tianjin) Pharmaceutical Co., Ltd. (Diamicron)
4.3 Tianjin Huajin Pharmaceutical Co. Ltd. (Diamicron)
4.4 Nanchang Helioeast Pharmaceutical Co., Ltd. (Hongxuyang)
4.5 Guilin Hwasun Pharmaceutical Co., Ltd. (Xieerping)
5 Prospect of China's Gliclazide Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend
Chart Sales of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide in Parts of China, 2013-2017
Chart Sales Volume of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide Tablets in China, 2013-2017
Chart Sales Value of Gliclazide Capsules in China, 2013-2017
Chart Market Share of Top 5 Gliclazide Manufacturers by Sales Value in China, 2013-2017
Chart Profile of Servier
Chart Sales Value of Servier's Gliclazide in China, 2013-2017
Chart Sales Value of Servier (Tianjin) Pharmaceutical Co., Ltd.'s Gliclazide in China, 2013-2017
Chart Sales Value of Servier Tianjin Huajin Pharmaceutical Co. Ltd.'s Gliclazide in China, 2013-2017
Chart Prices of Servier's Gliclazide in Parts of China, 2017-2018
Chart Prices of Servier (Tianjin) Pharmaceutical Co., Ltd.'s Gliclazide in Parts of China, 2017-2018
Chart Prices of Tianjin Huajin Pharmaceutical Co. Ltd.'s Gliclazide in Parts of China, 2017-2018
Chart Governmental Approval of Gliclazide in China
Chart Forecast on Sales Value of Gliclazide in China, 2018-2012
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.